Chul S Ha

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Clinical implications of incorporating heterogeneity corrections in mantle field irradiation
    Steven M Kirsner
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 55:1135-42. 2003
  2. ncbi Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
    Deborah A Thomas
    Department of Leukemia, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA
    Blood 104:1624-30. 2004
  3. ncbi Localized non-Hodgkin lymphoma involving the thyroid gland
    C S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Cancer 91:629-35. 2001
  4. ncbi Stage III follicular lymphoma: long-term follow-up and patterns of failure
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:748-54. 2003
  5. ncbi The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma
    Bouthaina S Dabaja
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Box 97, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 94:2738-44. 2002
  6. ncbi Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:316-20. 2003
  7. ncbi Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma
    C S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 92:1074-9. 2001
  8. ncbi A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:188-93. 2005
  9. ncbi The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)
    C S Ha
    Department of Radiation Oncology, Box 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 49:727-32. 2001
  10. ncbi Lymphoma
    Chul S Ha
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Unit 97, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiographics 26:607-20. 2006

Detail Information

Publications45

  1. ncbi Clinical implications of incorporating heterogeneity corrections in mantle field irradiation
    Steven M Kirsner
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 55:1135-42. 2003
    ....
  2. ncbi Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
    Deborah A Thomas
    Department of Leukemia, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA
    Blood 104:1624-30. 2004
    ..Other modifications of the program could include incorporation of monoclonal antibodies and/or nucleoside analogs, particularly for slow responders or those with residual mediastinal disease...
  3. ncbi Localized non-Hodgkin lymphoma involving the thyroid gland
    C S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Cancer 91:629-35. 2001
    ..The current study was undertaken to define the natural history and patterns of failure of localized non-Hodgkin lymphoma (NHL) involving the thyroid gland...
  4. ncbi Stage III follicular lymphoma: long-term follow-up and patterns of failure
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:748-54. 2003
    ..To analyze the long-term outcomes and pattern of failures for Stage III follicular lymphomas...
  5. ncbi The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma
    Bouthaina S Dabaja
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Box 97, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 94:2738-44. 2002
    ..The objective of this study was to investigate the role of mediastinal radiation therapy in patients who achieve a complete response (CR) to chemotherapy...
  6. ncbi Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:316-20. 2003
    ..This study was undertaken to update our experience with follicular lymphoma treated with central lymphatic irradiation (CLI)...
  7. ncbi Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma
    C S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 92:1074-9. 2001
    ..Hematologic toxicity has been considered a major consequence of CLI. This study was undertaken to analyze the patterns of hematologic recovery after CLI...
  8. ncbi A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:188-93. 2005
    ..MR was defined as disappearance of t(14;18) (q32;q21) amplified by polymerase chain reaction (PCR)...
  9. ncbi The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)
    C S Ha
    Department of Radiation Oncology, Box 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 49:727-32. 2001
    ....
  10. ncbi Lymphoma
    Chul S Ha
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Unit 97, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiographics 26:607-20. 2006
  11. ncbi Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome
    C S Ha
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 89:1371-9. 2000
    ....
  12. ncbi Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study
    C S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Int J Radiat Oncol Biol Phys 45:1207-12. 1999
    ..Therefore, we investigated the feasibility of treating patients in whom front-line chemotherapy failed with salvage CLI instead of instituting more intensive chemotherapy...
  13. ncbi Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)
    Chul S Ha
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    Cancer J 10:49-53. 2004
    ..This study was undertaken to study the molecular response rate of follicular lymphoma to C(H)OP-based therapy and to analyze prognostic factors for molecular response...
  14. ncbi An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
    Gregory M Chronowski
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:2534-8. 2002
    ..The relative importance of prognostic factors in patients with early-stage Hodgkin disease remains controversial. The purpose of this study was to evaluate prognostic factors among patients who received chemotherapy before radiotherapy...
  15. ncbi Radiotherapy alone for lymphocyte-predominant Hodgkin's disease
    Pamela J Schlembach
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    Cancer J 8:377-83. 2002
    ..The purpose of the study was to analyze the results with radiotherapy alone in a select group of asymptomatic adults with nonbulky, early-stage lymphocyte-predominant Hodgkin's disease...
  16. ncbi Second malignancies after chemotherapy and radiotherapy for Hodgkin disease
    Gregory M Chronowski
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Clin Oncol 27:73-80. 2004
    ..08). In an effort to reduce the risk of second malignancies, we have stopped using the alkylating agents nitrogen mustard and procarbazine and elective paraaortic and splenic radiotherapy after chemotherapy...
  17. ncbi Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy
    Gregory M Chronowski
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 55:36-43. 2003
    ..Cardiac toxicity and second malignancies, particularly the incidence of solid tumors in terms of the RT field size treated, were also examined...
  18. ncbi European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease
    Richard B Wilder
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 94:1731-8. 2002
    ....
  19. ncbi International prognostic index-based outcomes for diffuse large B-cell lymphomas
    Richard B Wilder
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 94:3083-8. 2002
    ..We present the results of doxorubicin-based chemotherapy with or without involved-field radiotherapy for patients with diffuse large B-cell lymphoma (DLBCL) according to the international prognostic index (IPI)...
  20. ncbi Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma
    Richard B Wilder
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 94:601-5. 2002
    ....
  21. ncbi Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy
    Bouthaina S Dabaja
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 98:1021-8. 2003
    ....
  22. ncbi Uncertainties in contemporary treatment of aggressive lymphomas
    James D Cox
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Rays 28:289-92. 2003
    ..This issue is even more complex now that intensity-modulated irradiation has become widely available. It is unlikely that these questions will be addressed in randomized clinical trials...
  23. ncbi Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas
    Hoon K Lee
    Department of Radiation Oncology, Box 97, M D Anderson Cancer Center, 1515 Holcombe Blvd, University of Texas, Houston, TX 77030 4009, USA
    Leuk Lymphoma 43:1769-75. 2002
    ..Based on the significant risk of relapse at the initial site of disease, different approaches, including chemotherapy with concomitant radiotherapy to doses > or = 45 Gy, warrant investigation...
  24. ncbi The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia
    Kevin E Sanders
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:2176-80. 2004
    ..However, to the authors' knowledge, the role of CSI in adults with a CNS recurrence of leukemia is unknown...
  25. ncbi Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma
    Bouthaina S Dabaja
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 9:321-4. 2003
    ..However, it can present in non-GI primary sites. This study was conducted to determine the incidence of gastric involvement in non-GI presentation of MALT lymphoma...
  26. ncbi Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease
    M L Meistrich
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 15:3488-95. 1997
    ....
  27. ncbi Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy
    Valerie Reed
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:4468-74. 2011
    ..The objective of this study was to review the outcome of patients with solitary plasmacytoma (SP) after definitive radiation therapy...
  28. ncbi Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study
    Heunglae Cho
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Anticancer Res 29:4409-15. 2009
    ..Imexon is already in clinical trials in patients with advanced solid tumors. The present study examined the effects of imexon on H9 and Raji lymphoma cell lines in vitro when given in combination with ionizing radiation...
  29. ncbi Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone
    Richard B Wilder
    Department of Radiation Oncology, M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 94:1532-7. 2002
    ..The authors analyzed multiple factors for myeloma-free survival (MFS) and cause-specific survival (CSS) in SPB patients treated with RT alone...
  30. ncbi Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro
    Masashi Koto
    Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan
    Anticancer Res 31:33-8. 2011
    ..Because astrocytes have been shown to reduce radiation-induced neuronal toxicity, this study hypothesized that astrocytes might protect lymphoma cells from radiation-induced cell killing...
  31. ncbi Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
    P Kebriaei
    Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Bone Marrow Transplant 38:203-9. 2006
    ....
  32. ncbi Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy
    A H Sarris
    Department of Lymphoma and Myeloma, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 19:398-405. 2001
    ..Establish frequency, presenting features, response and relapse patterns, and outcome of primary cutaneous non-Hodgkin's lymphoma (PCNHL)...
  33. ncbi Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy
    R B Wilder
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4095, USA
    Int J Radiat Oncol Biol Phys 49:17-22. 2001
    ....
  34. ncbi Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment
    C E Pelloski
    Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Radiother Oncol 59:145-51. 2001
    ..In patients with aggressive lymphomas, chemotherapy with or without radiotherapy resulted in excellent local control, progression-free survival, and overall survival; however, the statistical power was limited...
  35. ncbi Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas
    R B Wilder
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 50:743-9. 2001
    ..To analyze the results with involved-field radiotherapy after aggressive lymphomas had decreased in size by 50-99% in response to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)-based chemotherapy...
  36. ncbi Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
    R B Wilder
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 91:2440-6. 2001
    ....
  37. ncbi Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure
    Z Liao
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 50:971-7. 2001
    ..Late complications of the treatment pose a significant threat for the patient's survival with long-term follow-up...
  38. ncbi Long-term results with radiotherapy for Stage I-II follicular lymphomas
    R B Wilder
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 51:1219-27. 2001
    ..To analyze the long-term results with radiotherapy (RT) for early-stage, low-grade follicular lymphomas...
  39. ncbi Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma
    Madeleine Duvic
    Division of Internal Medicine, Department of Dermatology, University of Texas M D Anderson Cancer Center, Houston 77030 4095, USA
    J Am Acad Dermatol 49:35-49. 2003
    ....
  40. ncbi Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
    R Gopal
    Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Cancer 92:1949-58. 2001
    ..The increased dose may contribute to a decrease in the recurrence rate in these patients. (c) 2001 American Cancer Society...
  41. ncbi Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation
    David G Kornguth
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1840 Old Spanish Trail, Houston, TX 77054, USA
    Int J Radiat Oncol Biol Phys 68:1140-4. 2007
    ....
  42. ncbi Multiple myeloma of the cervical spine: treatment strategies for pain and spinal instability
    Ganesh Rao
    Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Neurosurg Spine 5:140-5. 2006
    ..The results of radiation therapy for multiple myeloma metastases to the cervical spine that cause clinical or radiographically documented instability have not been reported previously...
  43. ncbi Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors
    James E Baumgartner
    Division of Pediatric Surgery Neurosurgery, University of Texas Medical School, Houston, Tex 77030, USA
    Pediatr Neurosurg 39:201-7. 2003
    ..They are radiologically and pathologically similar to sporadically occurring CAs of the brain and may enlarge over time and become symptomatic. CAs can be safely resected using standard microsurgical techniques...
  44. ncbi Radiotherapy and Hodgkin's lymphoma
    Prajnan Das
    J Clin Oncol 23:8914; author reply 8914-6. 2005
  45. ncbi Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma
    John F Seymour
    Department of Haematology, The Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia
    J Clin Oncol 21:2115-22. 2003
    ..We investigated the potential for combined-modality therapy to increase the disease-free survival for such patients...